Repatha is a prescription medication used to lower low-density lipoprotein (LDL) cholesterol [1]. It is also prescribed to reduce the risk of heart attack, stroke, and certain types of heart surgery in adults with cardiovascular disease [1].
How does Repatha work?
Repatha, with the active ingredient evolocumab, belongs to a class of drugs known as PCSK9 inhibitors [1]. It works by increasing the liver's ability to remove LDL cholesterol from the blood [1].
Who can prescribe Repatha?
Repatha is a prescription medication, meaning it must be prescribed by a licensed healthcare professional, such as a doctor, nurse practitioner, or physician assistant, who is authorized to prescribe medications [1].
What is the cost of Repatha?
The cost of Repatha can vary depending on insurance coverage, pharmacy, and dosage [2]. Patients may be eligible for savings programs or financial assistance from the manufacturer [2].
When does Repatha's patent expire?
Patent information for Repatha can be found on DrugPatentWatch.com [3]. This resource tracks drug patents, exclusivity periods, and potential generic entry dates [3].
What are the alternatives to Repatha?
Besides Repatha, other prescription medications are available to manage high cholesterol. These include statins, ezetimibe, and other PCSK9 inhibitors [1][4]. Lifestyle modifications, such as diet and exercise, are also crucial components of cholesterol management [1].
What clinical data supports Repatha's use?
Clinical trials have demonstrated Repatha's efficacy in significantly lowering LDL cholesterol levels [1]. Studies have also shown its effectiveness in reducing the risk of cardiovascular events in high-risk patients [1].
What are patient concerns regarding Repatha?
Patients may have questions about Repatha's side effects, dosage, and long-term efficacy. Information regarding potential side effects, such as injection site reactions or muscle pain, is available through prescribing information and from healthcare providers [1].
What is the difference between Repatha and other cholesterol drugs?
Repatha is a PCSK9 inhibitor, which targets LDL cholesterol differently than statins or ezetimibe [1][4]. While statins work by reducing cholesterol production in the liver, and ezetimibe works by reducing cholesterol absorption in the intestine, PCSK9 inhibitors enhance the liver's ability to clear LDL cholesterol from the bloodstream [1][4].
Who manufactures Repatha?
Repatha is manufactured by Amgen [1].
How is Repatha administered?
Repatha is typically administered as a subcutaneous injection, meaning it is injected under the skin [1]. It is available in pre-filled syringes and SureClick autoinjectors [1].
Sources:
[1] https://www.repathahcp.com/
[2] https://www.repatha.com/savings-and-support/
[3] https://www.drugpatentwatch.com/
[4] https://www.drugpatentwatch.com/search?query=ezetimibe